Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Benowitz

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Communications Biology|March 22, 2020
Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2Alina Mares, Afjal H Miah, Ian E D Smith, et al.
ACS Chemical Biology|November 2, 2025
Orthogonal IMiD-Degron Pairs Induce Selective Protein Degradation in CellsPatrick J Brennan, Rebecca E Saunders, Mary Spanou, et al.
Nature Cancer|November 18, 2021
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemiaMelissa B Pappalardi, Kathryn Keenan, Mark Cockerill, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Communications Biology|March 22, 2020
Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2Alina Mares, Afjal H Miah, Ian E D Smith, et al.
ACS Chemical Biology|November 2, 2025
Orthogonal IMiD-Degron Pairs Induce Selective Protein Degradation in CellsPatrick J Brennan, Rebecca E Saunders, Mary Spanou, et al.
Nature Cancer|November 18, 2021
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemiaMelissa B Pappalardi, Kathryn Keenan, Mark Cockerill, et al.
Pageof 3